Challenges in Ensuring Equity In the Study and Treatment of ME/CFS and Long Covid
Co-presented by Peter Rowe, MD (Professor of Pediatrics, Director, Johns Hopkins Children’s Center Chronic Fatigue Clinic) and Camille Broussard, MD, MPH (Assistant Professor in the Division of Adolescent and Young […]
Solve M.E. Engages New Community Partners Through Lived Experience Taskforce (LET)
Building on our commitment to centering the crucial voices from our community in the leadership and decision-making at Solve M.E., we are transforming our Community Advisory Council (2019 – 2022) […]
Long Covid in the Media
Solve M.E. is continuing our event series with the Global Interdependence Center with a panel on November 29 10AM PT. The sixth installment of the GIC Solve Long Covid Initiative […]
Solve Ramsay Grant Scientists Among Those Awarded Nearly $5 Million for Biomedical Research
This week the Patient-Led Research Collaborative (PLRC) announced $4.8 million in biomedical research awards for Long Covid and associated conditions. Nine research projects in Long Covid, ME/CFS, dysautonomia, and associated […]
Fiona Lowenstein, Dona Kim Murphey and The Long Covid Survival Guide
For people living with Long Covid, navigating the uncharted territory of this new chronic illness can be challenging. With over two hundred unique symptoms, and with doctors continuing to work […]
Solve M.E. & Community Partners Denounce Misleading New York Magazine Article
The article published in NY Magazine on Nov 4, 2022, “Has Long COVID Always Existed? The pandemic might not have spawned a new chronic illness but rebranded an old one,” […]
Understanding the Biomarkers of PASC (otherwise known as Long Covid)
The RECOVER Research Review (R3) Seminar Series will host a panel discussion titled, “Understanding the Biomarkers of PASC” on Tuesday, November 8th 12:00-1:30 PM EDT featuring: Michael Peluso, MD, University […]
RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS
The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. […]
COVID-19 as a Trigger for ME/CFS: Severity Biomarkers and Underlying Mechanisms
Since the beginning of the pandemic, SARS-CoV-2 has been suspected of causing chronic fatigue syndrome (ME/CFS). A well-controlled cohort study conducted by a group of researchers from Charité – Universitätsmedizin […]
World ME Alliance calls on WHO Director General to recognize ME/CFS alongside Long Covid
On Wednesday 12th October Dr. Tedros Ghebreyesus, Director General of the World Health Organization, wrote an op-ed in the Guardian. In it, he lays clear the devastation that Long Covid […]
New Ramsay Grant Researchers Push the Envelope with Innovative ME/CFS & Long Covid studies
We’re excited to share the newest class of Ramsay Researchers! Since its launch, our Ramsay Research Grant Program has been successful in attracting new scientists to the fields of ME/CFS […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
